These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7849546)

  • 1. The effect of alendronate on renal tubular reabsorption of phosphate.
    Vasikaran SD; O'Doherty DP; McCloskey EV; Gertz B; Kahn S; Kanis JA
    Bone Miner; 1994 Oct; 27(1):51-6. PubMed ID: 7849546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.
    Adami S; Zamberlan N; Mian M; Dorizzi R; Rossini M; Braga B; Gatti D; Bertoldo F; Locascio V
    Bone Miner; 1994 May; 25(2):75-82. PubMed ID: 8086853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intravenous alendronate in Paget's disease of bone.
    O'Doherty DP; McCloskey EV; Vasikaran S; Khan S; Kanis JA
    J Bone Miner Res; 1995 Jul; 10(7):1094-100. PubMed ID: 7484285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphosphonates and phosphate homoeostasis in man.
    McCloskey EV; Yates AJ; Gray RE; Hamdy NA; Galloway J; Kanis JA
    Clin Sci (Lond); 1988 Jun; 74(6):607-12. PubMed ID: 3396298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate.
    Constantin A; Laroche M; Moulinier L; Bon E; Ramonjisoa M; Cantagrel A; Mazieres B
    Rev Rhum Engl Ed; 1995; 62(7-8):493-500. PubMed ID: 8574612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The maximal tubular reabsorption of phosphate in relation to serum parathyroid hormone.
    Madsen S; Olgaard K; Ladefoged J
    Adv Exp Med Biol; 1977; 81():141-8. PubMed ID: 899923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP; Gertz BJ; Tindale W; Sciberras DG; Survill TT; Kanis JA
    J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
    Adami S; Frijlink WB; Bijvoet OL; O'Riordan JL; Clemens TL; Papapoulos SE
    Calcif Tissue Int; 1982 Jul; 34(4):317-20. PubMed ID: 6814718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Alpha-hydroxycholecalciferol-induced changes in the renal heandling of phosphate and the serum parathyroid hormone level.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(5):351-4. PubMed ID: 983805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous sodium lactate on renal tubular reabsorption of phosphate in man.
    Walton RJ
    Clin Sci (Lond); 1979 Jul; 57(1):125-7. PubMed ID: 38939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor influence of parathyroid hormone on fractional tubular reabsorption of phosphate in chronic renal failure.
    Christensen MS; Brochner-Mortensen J; Tougaard L; Sorensen E; Rodbro P
    Adv Exp Med Biol; 1977; 81():131-9. PubMed ID: 899922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosis.
    Masaki H; Imanishi Y; Naka H; Nagata Y; Kurajoh M; Mori K; Emoto M; Miki T; Inaba M
    J Bone Miner Metab; 2020 May; 38(3):405-411. PubMed ID: 31897746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risedronate: a new oral bisphosphonate.
    Umland EM; Boyce EG
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced tubular reabsorption of phosphate during post-operative glucose infusions in humans.
    Rasmussen A; Jespersen L
    Eur J Clin Invest; 1985 Jun; 15(3):157-60. PubMed ID: 3926511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of phosphate in relation to serum parathyroid hormone levels.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(1-2):7-10. PubMed ID: 785962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate reaches U.S. market for osteoporosis, Paget's disease.
    Am J Health Syst Pharm; 1995 Nov; 52(22):2513-4. PubMed ID: 8590234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.